Corbus Pharmaceuticals Holdings, Inc. (CRBP)
11.12
-0.34
(-2.97%)
USD |
NASDAQ |
Sep 04, 16:00
11.12
0.00 (0.00%)
After-Hours: 16:03
Corbus Pharmaceuticals Holdings Debt to Equity Ratio : 0.0417 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0417 |
| March 31, 2026 | 0.0095 |
| December 31, 2025 | 0.0111 |
| September 30, 2025 | 0.0222 |
| June 30, 2025 | 0.0221 |
| March 31, 2025 | 0.0225 |
| December 31, 2024 | 0.0227 |
| September 30, 2024 | 0.024 |
| June 30, 2024 | 0.1179 |
| March 31, 2024 | 0.1783 |
| December 31, 2023 | -3.025 |
| September 30, 2023 | 73.49 |
| June 30, 2023 | 2.491 |
| March 31, 2023 | 1.509 |
| December 31, 2022 | 0.7605 |
| September 30, 2022 | 0.6084 |
| June 30, 2022 | 0.5203 |
| March 31, 2022 | 0.4279 |
| December 31, 2021 | 0.3848 |
| September 30, 2021 | 0.3337 |
| June 30, 2021 | 0.3389 |
| March 31, 2021 | 0.2892 |
| December 31, 2020 | 0.5927 |
| September 30, 2020 | 0.8959 |
| June 30, 2020 | 0.1775 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.3982 |
| December 31, 2019 | 1.534 |
| September 30, 2019 | 0.2809 |
| June 30, 2019 | 0.1629 |
| March 31, 2019 | 0.1789 |
| December 31, 2018 | 0.0143 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.0016 |
| March 31, 2018 | 0.0032 |
| December 31, 2017 | 0.0058 |
| September 30, 2017 | 0.0002 |
| June 30, 2017 | 0.0012 |
| March 31, 2017 | 0.0037 |
| December 31, 2016 | 0.0314 |
| September 30, 2016 | 0.0007 |
| June 30, 2016 | 0.0019 |
| March 31, 2016 | 0.0164 |
| December 31, 2015 | 0.018 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.0155 |
| December 31, 2014 | 0.0246 |
| September 30, 2014 | 0.0107 |
| June 30, 2014 | 0.0857 |
| March 31, 2014 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Anika Therapeutics, Inc. | 0.1839 |
| Savara, Inc. | 0.2117 |
| Vericel Corp. | 0.2556 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 126.99M |
| Total Liabilities (Quarterly) | 24.75M |
| Shareholders Equity (Quarterly) | 102.24M |
| Current Ratio | 5.714 |
| Net Debt Paydown Yield | -0.16% |